SPL cannot even get Astrazeneca thus far to commit more than a...

SPL cannot even get Astrazeneca thus far to commit more than a few million in milestone payments here and there over many years, so I doubt they would have the ability to convince Pfizer to fork out tens of millions out of this investment allocation ? lol

Just bring on the phase 2 DEP® docetaxel trial results I say and see what deals we can muster from there .... that is of course if they are not delayed yet again ?

I guess we should remember SPL haven't delivered anything on time so I am guessing the ability to use COVID-19 as an excuse to push out results is inevitable even though most places in the UK managed to continue dosing and treatment of cancer patients during the pandemic

https://medicalxpress.com/news/2020-06-repurposed-drug-covid-trial-cancer.html

Rapidly responding and contributing to the COVID-19 effort, without redirecting efforts from cancer patients with the CDD still able to continue treatment for all cancer patients on their trials.